OncoSwab
PrivateLast Round
Grant
May 5, 2025
Total Funding Raised
$4.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OncoSwab operates in Healthcare & Life Sciences and is based in Courroux. Its latest recorded funding round was a Grant round in May 2025.
OncoSwab is a biotechnology company developing a non-invasive, nasal swab-based diagnostic platform for the early detection of lung cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoSwab Comparables
Compare OncoSwab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulmostics | 78% | |
| Veracyte | 73% | |
| Delfi Diagnostics | 70% |
For institutional investors. Book with your work email.
OncoSwab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2025 | ||||
| Pre Seed | Oct 25, 2024 | ||||
| Pre Seed | Mar 12, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OncoSwab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Switzerland Innovation | Pre Seed |
| Basel Area Business & Innovation | Pre Seed |
| European Institute of Innovation and Technology | Pre Seed |
| University of Toronto Asset Management Corporation | Pre Seed |
| Creative Destruction Lab | Pre Seed |
| DayOne | Pre Seed |
| Innosuisse | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 317% MoM, reaching 1.2K.
- May 5, 2025
Secured $1.58M in grant funding.
For institutional investors. Book with your work email.
OncoSwab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoSwab's valuation, stock price, and market status.
Is OncoSwab a public or private company?
OncoSwab is a private company.
What is the current stock price of OncoSwab?
OncoSwab is a private company, so its shares have no public market price. Caplight tracks OncoSwab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoSwab worth (valuation)?
Valuation information for OncoSwab is not publicly available.
Can I buy OncoSwab stock?
OncoSwab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoSwab's last funding round?
OncoSwab's most recent funding round was Grant on May 5, 2025.
Who are the main investors in OncoSwab?
Key investors in OncoSwab include Innosuisse.
Will OncoSwab IPO soon?
No public IPO plans have been announced for OncoSwab.
How can I track OncoSwab secondary market activity?
Caplight tracks bids, offers, and trades in OncoSwab's shares on secondary markets.